JOHNS HOPKINS MEDICINE RED STAIN IS ACE2. THE GREEN PROBE IS STAINING CK18, WHICH IS FOUND IN SUPPORTING CELLS AND MUCUS GLANDS. view more CREDIT: PHOTO BY MENGFEI CHEN Scientists at Johns Hopkins Medicine, experimenting with a small number of human cell samples, report that the “hook” of cells used by SARS-CoV-2 to latch onto...
Estimation of incubation period distribution of COVID-19 using disease onset forward time: A novel cross-sectional and forward follow-up study AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE By applying the renewal theory in probability to reduce recall bias in initial case reports, scientists have come up with a new estimate for the incubation period of COVID-19....
American Journal of Pathology publishes efficacy results from Houston Methodist clinical trial HOUSTON METHODIST HOUSTON METHODIST PHYSICIAN SCIENTIST ERIC SALAZAR, MD, PHD, LOOKS ON AS HIS TEAM WORKS IN THE LAB ON CONVALESCENT PLASMA RESEARCH. view more CREDIT: HOUSTON METHODIST HOUSTON-(Aug. 12, 2020) – A preliminary analysis of an ongoing study of more than 300...
by Johns Hopkins University A cutaway diagram of the ear showing the two regions — the middle ear and mastoid air cells (as indicated by the red arrows) — from where Johns Hopkins researchers recently isolated the SARS-CoV-2 virus (seen at upper right), the cause of COVID-19. Credit: Graphic by M.E. Newman, Johns Hopkins Medicine,...
Frankfurt scientists identify possible Achilles’ heel of SARS-CoV-2 virus GOETHE UNIVERSITY FRANKFURT In the case of an infection, the SARS-CoV-2 virus must overcome various defense mechanisms of the human body, including its non-specific or innate immune defense. During this process, infected body cells release messenger substances known as type 1 interferons. These attract natural killer...
Absorbed plant MIR2911 in honeysuckle decoction inhibits SARS-CoV-2 replication and accelerates the negative conversion of infected patients NANJING UNIVERSITY SCHOOL OF LIFE SCIENCES A practicable and reliable therapeutic strategy to treat SARS-CoV-2 infection: absorbed plant MIR2911 in honeysuckle decoction inhibits SARS-CoV-2 replication and accelerates the negative conversion of infected patients In a new study in...
By Sally Robertson, B.Sc. A study conducted by researchers in the UK and Italy suggests that individuals with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are probably at their most infectious during the first week of illness. The systematic review and meta-analysis of data available on the viral dynamics of SARS-CoV-2 found that although viral...
Researchers are scrambling to find other ways to diagnose the coronavirus and churn out millions of tests a week — a key step in returning to normality. The timing couldn’t have been worse. In March, just as Thailand’s coronavirus outbreak began to ramp up, three hospitals in Bangkok announced that they had suspended testing for...
An investigational vaccine, mRNA-1273, designed to protect against SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), was generally well tolerated and prompted neutralizing antibody activity in healthy adults, according to interim results published online in The New England Journal of Medicine. The ongoing Phase 1 trial is supported by the National Institute of Allergy...
RADIOLOGICAL SOCIETY OF NORTH AMERICA OAK BROOK, Ill. (July 16, 2020) – COVID-19 is associated with life-threatening blood clots in the arteries of the legs, according to a study published in Radiology. Researchers said COVID-19 patients with symptoms of inadequate blood supply to the lower extremities tend to have larger clots and a significantly higher...
